Oleuropein induces apoptosis via abrogating NF-κB activation cascade in estrogen receptor-negative breast cancer cells.


Journal

Journal of cellular biochemistry
ISSN: 1097-4644
Titre abrégé: J Cell Biochem
Pays: United States
ID NLM: 8205768

Informations de publication

Date de publication:
03 2019
Historique:
received: 19 06 2018
accepted: 30 08 2018
pubmed: 28 9 2018
medline: 19 3 2020
entrez: 28 9 2018
Statut: ppublish

Résumé

Oleuropein is one of the most abundant phenolic compounds found in olives. Epidemiological studies have indicated that an increasing intake of olive oil can significantly reduce the risk of breast cancer. However, the potential effect(s) of oleuropein on estrogen receptor (ER)-negative breast cancer is not fully understood. This study aims to understand the anticancer effects and underlying mechanism(s) of oleuropein on ER-negative breast cancer cells in vitro. The effect of oleuropein on the viability of breast cancer cell lines was examined by mitochondrial dye-uptake assay, apoptosis by flow cytometric analysis, nuclear factor-κB (NF-κB) activation by DNA binding/reporter assays and protein expression by Western blot analysis. In the present report, thiazolyl blue tetrazolium bromide assay results indicated that oleuropein inhibited the viability of breast cancer cells, and its effects were more pronounced on MDA-MB-231 as compared with MCF-7 cells. It was further found that oleuropein increased the level of reactive oxygen species and also significantly inhibited cellular migration and invasion. In addition, the activation of NF-κB was abrogated as demonstrated by Western blot analysis, NF-κB-DNA binding, and luciferase assays. Overall, the data indicates that oleuropein can induce substantial apoptosis via modulating NF-κB activation cascade in breast cancer cells.

Identifiants

pubmed: 30260018
doi: 10.1002/jcb.27738
doi:

Substances chimiques

Iridoid Glucosides 0
Iridoids 0
NF-kappa B 0
Receptors, Estrogen 0
oleuropein 2O4553545L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4504-4513

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Lian Liu (L)

Department of Pharmacology, Medical School of Yangtze University, Jingzhou, China.
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Kwang Seok Ahn (KS)

Department of Korean Pathology, College of Korean Medicine, Kyung Hee University, Seoul, Korea.

Muthu K Shanmugam (MK)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Hong Wang (H)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Radiobiology Research Laboratory, Singapore Nuclear Research and Safety Initiative, National University of Singapore, Singapore.

Hongyuan Shen (H)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Radiobiology Research Laboratory, Singapore Nuclear Research and Safety Initiative, National University of Singapore, Singapore.

Frank Arfuso (F)

Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, Australia.

Arunachalam Chinnathambi (A)

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Sulaiman Ali Alharbi (SA)

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Yung Chang (Y)

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
R&D Center for Membrane Technology and Department of Chemical Engineering, Chung Yuan Christian University, Taoyuan, Taiwan.

Gautam Sethi (G)

Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Feng Ru Tang (FR)

Radiobiology Research Laboratory, Singapore Nuclear Research and Safety Initiative, National University of Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH